Alpine Fox Capital »

Regeneron Pharmaceuticals shares owned by Alpine Fox Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Alpine Fox Capital from 13F filings

Historical chart of Alpine Fox Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Alpine Fox Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Alpine Fox Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $773k 1.0k 772.64

More positions owned by Alpine Fox Capital

Cipher Mining (CIFR)
iShares Bitcoin Trust ETF Shs Ben Int Call Option (IBIT)
Iren Ord Shs (IREN)
iShares Ethereum Trust ETF SHS (ETHA)
Opendoor Technologies (OPEN)
Strive Cl A Com (ASST)
Novo-Nordisk A/S Adr (NVO)
BitMine Immersion Technologies Com New (BMNR)
Pepsi (PEP)
Regeneron Pharmaceuticals (REGN)
Constellation Brands Cl A (STZ)
Canadian Pacific Kansas City (CP)
Bakkt Com Cl A New (BKKT)
Target Corporation (TGT)

View all positions for Alpine Fox Capital

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Vanguard Portfolio Management
Goldman Sachs Group
Capital World Investors
Susquehanna International

View all funds holding Regeneron Pharmaceuticals